Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
QIAGEN Signs AI Drug Discovery Deal with NVIDIA Integrating BioNeMo Platform
QIAGEN and NVIDIA integrate BioNeMo AI platform with biomedical knowledge bases to accelerate drug discovery and compress early R&D timelines.
Pharma Now Editorial Team
Boehringer Ingelheim India Signs MoUs with NIPER Ahmedabad and Hyderabad to Expand Research Collaboration
Boehringer Ingelheim India extends its NIPER collaboration to Ahmedabad and Hyderabad, covering four campuses and opening opnMe platform access.
Pharma Now Editorial Team
Takeda Pharma Ordered to Pay $2.5 Billion After Jury Finds Amitiza Pay-for-Delay Agreement Anticompetitive
A US federal jury ordered Takeda to pay $2.5 billion, finding its Amitiza pay-for-delay agreement anticompetitive and a barrier to generic market entry.
Pharma Now Editorial Team
Hansa Biopharma Licenses IDEFIRIX to SERB Pharmaceuticals in €115M European Deal
Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in a €115M deal, shifting European commercialization of imlifidase to a rare disease specialist.
Pharma Now Editorial Team
